InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Ullman Anders, Director. Officer active across 1 company, notably Verona Pharma plc. In total, 3 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €8k. Activity tracked since 4 May 2021. The latest transaction was filed on 1 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ullman Anders
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
358,856 股Ordinary SharesSEC:0001104659-25-097959:0
24,000 股0Ordinary SharesSEC:0001104659-25-074380:0
12,056 股@ US$0.8397100.0% 占其流量Ordinary SharesSEC:0001104659-21-061812:0
3 条申报中的 3 条
About Ullman Anders
Anders Ullman is a Board Member at Verona Pharma plc. He plays a key role in the governance of the company, participating in strategic decision-making. Verona Pharma plc is a biopharmaceutical company specializing in developing treatments for respiratory diseases.
